Authors' Reply to Ravi Jandhyala's Comment on "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments"
View/ Open
Published version
Embargoed until: 5555-01-01
Reason: Version not permitted
Embargoed until: 5555-01-01
Reason: Version not permitted
Volume
42
Pagination
1517 - 1518
DOI
10.1007/s40264-019-00863-w
Journal
DRUG SAFETY
Issue
ISSN
0114-5916